PRESS RELEASE published on 08/25/2025 at 07:00, 9 months 30 days ago OSE Immunotherapeutics Proposes Governance Evolution and Reaffirms Strategic Priorities ahead of Annual General Meeting OSE Immunotherapeutics announces proposed governance evolution and reaffirms strategic priorities ahead of Annual General Meeting. Company focuses on Tedopi® and Lusvertikimab to unlock full potential Strategic Priorities Governance Evolution OSE Immunotherapeutics Lusvertikimab Tedopi
BRIEF published on 08/20/2025 at 18:05, 10 months 4 days ago OSE Immunotherapeutics Appoints Thomas Gidoin as CFO Chief Financial Officer Strategic Planning Biotech Financing OSE Immunotherapeutics Thomas Gidoin
BRIEF published on 08/20/2025 at 18:05, 10 months 4 days ago OSE Immunotherapeutics nomme Thomas Gidoin au poste de directeur financier Directeur Financier Planification Stratégique OSE Immunotherapeutics Financement Des Biotechnologies Thomas Gidoin
PRESS RELEASE published on 08/20/2025 at 18:00, 10 months 4 days ago OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer OSE Immunotherapeutics appoints Thomas Gidoin as Chief Financial Officer, bringing deep expertise in capital markets and financial strategy to the company. Gidoin succeeds Anne-Laure Autret-Cornet Chief Financial Officer Capital Markets Financial Strategy OSE Immunotherapeutics Thomas Gidoin
PRESS RELEASE published on 08/20/2025 at 18:00, 10 months 4 days ago OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier Nomination de Thomas Gidoin comme nouveau Directeur Financier chez OSE Immunotherapeutics. Il apporte 15 ans d'expertise internationale en finance et gouvernance Biotechnologie Finance Directeur Financier OSE Immunotherapeutics Thomas Gidoin
BRIEF published on 07/02/2025 at 08:05, 11 months 22 days ago OSE Immunotherapeutics Updates on Legal Proceedings Transparency Shareholder Meeting Legal Proceedings OSE Immunotherapeutics Nantes Commercial Court
BRIEF published on 07/02/2025 at 08:05, 11 months 22 days ago Mises à jour d'OSE Immunotherapeutics sur les procédures judiciaires Transparence Assemblée Des Actionnaires OSE Immunotherapeutics Procédures Judiciaires Tribunal De Commerce De Nantes
PRESS RELEASE published on 07/02/2025 at 08:00, 11 months 22 days ago OSE Immunotherapeutics met à jour l’information sur les procédures en cours OSE Immunotherapeutics provides an update on ongoing legal proceedings regarding shareholders' motions, confirms plans for annual shareholders' meeting on September 30, 2025 Shareholders Biotech Annual Meeting Legal Proceedings OSE Immunotherapeutics
PRESS RELEASE published on 07/02/2025 at 08:00, 11 months 22 days ago OSE Immunotherapeutics met à jour l’information sur les procédures en cours Mise à jour des procédures en cours par OSE Immunotherapeutics concernant une action en justice et la tenue de leur assemblée générale annuelle. Vision prospective de l'entreprise Biotechnologie Procédures En Cours Déclarations Prospectives Assemblée Générale Annuelle OSE Immunotherapeutics
BRIEF published on 06/20/2025 at 19:35, 1 year ago OSE Immunotherapeutics sécurise son Assemblée Générale Actionnaires Assemblée Générale Transparence OSE Immunotherapeutics Procédures Judiciaires
Published on 06/25/2026 at 00:30, 27 minutes ago Northern Dynasty Reports Annual General Meeting Results and Welcomes New Directors
Published on 06/24/2026 at 23:05, 1 hour 52 minutes ago Polaris Modifies Quorum Requirement for Upcoming AGM
Published on 06/24/2026 at 22:15, 2 hours 42 minutes ago Organto Foods Announces Annual General Meeting Results
Published on 06/24/2026 at 21:20, 3 hours 37 minutes ago Taranis to Explore New Properties East of Thor Mineral Resource
Published on 06/24/2026 at 20:10, 4 hours 47 minutes ago Fox River Obtains Final Order Approving Plan of Arrangement With Avenir Minerals Limited
Published on 06/24/2026 at 23:57, 1 hour ago OHB: Upsized private placement worth EUR 900 million successfully completed
Published on 06/24/2026 at 20:54, 4 hours 2 minutes ago EQS-Adhoc: Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements
Published on 06/24/2026 at 18:25, 6 hours 32 minutes ago Huawei Helps Global Carriers Monetize Tokens with Service-Network-Compute Integration
Published on 06/24/2026 at 19:00, 5 hours 57 minutes ago ALTAREA - Succès de l’option pour le paiement du dividende en actions : taux de souscription de 78,5 %
Published on 06/24/2026 at 18:00, 6 hours 57 minutes ago KERLINK : Assemblée générale mixte des actionnaires du 23 juin 2026 Seconde convocation le 9 juillet 2026.
Published on 06/24/2026 at 17:45, 7 hours 12 minutes ago Air Liquide poursuit son développement au Kazakhstan avec un investissement clé pour le complexe industriel de Silleno
